Literature DB >> 212476

The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.

H J Field, P Wildy.   

Abstract

The pathogenicity for mice of two mutants of herpes simplex virus (type 1 and type 2), which fail to induce thymidine kinase, were compared with their respective parent strains. The mutants were much less virulent than the parents following either intracerebral or peripheral inoculation. The replication of the virus at the site of inoculation and its progression into the nervous system were studied. Following a very large inoculum in the ear, the type 1 mutant was found to establish a latent infection in the cervical dorsal root ganglia. Mice inoculated intracerebrally with small doses of the mutant viruses were solidly immune to challenge with lethal doses of the parent strain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212476      PMCID: PMC2129783          DOI: 10.1017/s0022172400025109

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Deoxypyrimidine kinases of herpes simplex viruses types 1 and 2: comparison of serological and structural properties.

Authors:  M E Thouless; P Wildy
Journal:  J Gen Virol       Date:  1975-02       Impact factor: 3.891

2.  Low virulence and immunogenicity in mice and in rabbits of variants of Herpes simplex virus resistant to 5-iodo-2-deoxyuridine.

Authors:  M A Marcialis; P La Colla; M L Schivo; O Flore; A Firinu; B Loddo
Journal:  Experientia       Date:  1975-04-15

3.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

4.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice.

Authors:  K W Lofgren; J G Stevens; H S Marsden; J H Subak-Sharpe
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

6.  Resistance to intracerebral challenge in mice immunized against herpes simplex virus.

Authors:  R C Godfrey
Journal:  Br J Exp Pathol       Date:  1972-10

7.  Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus.

Authors:  M E Thouless
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

8.  Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors:  D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

9.  A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus.

Authors:  H G Klemperer; G R Haynes; W I Shedden; D H Watson
Journal:  Virology       Date:  1967-01       Impact factor: 3.616

10.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

View more
  102 in total

1.  Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency.

Authors:  R B Pyles; N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

Review 3.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

4.  Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Authors:  M N Ellis; P M Keller; J A Fyfe; J L Martin; J F Rooney; S E Straus; S N Lehrman; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Vaccination of mice and swine with a pseudorabies virus mutant lacking thymidine kinase activity.

Authors:  M D McFarland; H T Hill
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

7.  Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping.

Authors:  G L Smith; A de Carlos; Y S Chan
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

8.  Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system.

Authors:  R B Pyles; R L Thompson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene.

Authors:  D C Bloom; J G Stevens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Pathologic studies and comparison of the virulence of herpes simplex virus type 2 from Okinawa, Japan and Chiang Mai, Thailand.

Authors:  K Sunagawa; W Sirirungsi; I Nakazato; T Hirayasu; T Iwamasa
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.